GC Genome (340450.KQ) Stock Price
GC Genome Price
Revenue has compounded at 11.8% per year over the past 3 years to 31.34 B KRW. GC Genome's net margin stands at 12.9%, up from -16.8% several years earlier.
GC Genome stock price
GC Genome business model & stock analysis
Frequently asked questions about GC Genome
Converted at the current exchange rate, the GC Genome share trades at 6.69 EUR (10,050.00 KRW).
The expected revenue of GC Genome is 39.00 B KRW. This figure is based on current financial data and reflects the company's business performance.
The expected profit of GC Genome is 5.42 B KRW. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of GC Genome is currently 43.89. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the GC Genome stock.
The price-to-sales ratio (P/S) of GC Genome is currently 6.09. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the GC Genome stock.
The Eulerpool Quality Score for GC Genome is 3/10.
The ISIN of GC Genome is KR7340450006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of GC Genome is 340450.KQ. The ticker symbol is used to trade GC Genome shares on the stock exchange.
GC Genome stock
GC Genome Peer Group
All fundamentals and in-depth analysis of GC Genome
Our stock analysis for GC Genome stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GC Genome. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.